The US Environmental Protection Agency has given the go-ahead to Monsanto for its RNAi-based insecticide, the Atlantic reports. It adds that this is the first approved RNAi insecticide.

"I would put RNA in the suite of really advanced, next-generation technologies that are adding to the excitement from a research perspective," Robb Fraley, the chief technology officer at Monsanto, tells the Atlantic.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.